RELAVO, INC

BROOKLYN, NY · Founded 2018 · Medtech · Private

Medical device that internally disinfects peritoneal dialysis catheter tubes in a closed system to prevent microbial infection

Claim this profile

Follows are private to you and power your alerts

Updated · relavo.io

Sector
Medtech
Headquarters
BROOKLYN, NY
Founded
2018
Latest Form D
$25K, Dec 2020
Total capital
$1.9M
Federal grants
$1.8M
2 awards · 2020–2022
Rank in peer group#302 of 538
Private capital raised
$175K
2 Form D · last Dec 2020
71 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
1
3 pending · first 2024
Rank in peer group#237 of 538

Capital timeline

202020212022FEDERAL ↑EQUITY ↓Cumulative $1.9M$256K$1.5M1st Form D$150K2nd Form D$25K
202020212022FEDERAL ↑EQUITY ↓Cumulative $1.9M$256K$1.5M1st Form D$150K2nd Form D$25K

Latest events

  • Federal grantNSF · Phase II · SBIR Phase II:A Novel Disinfection Method to Prevent Infection in Peritoneal Dialysis$1.5M
  • Private capital raisedForm D · SEC · 2nd filing$25K
  • Federal grantNSF · Phase I · SBIR Phase I: A Novel Disinfection Method to Prevent Infection in Peritoneal Dialysis$256K
  • Private capital raisedForm D · SEC · 1st filing$150K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 538 peers

Line = median

Medtech · Device

  • Federal grantsBelow median
  • Granted patents#237 · top 44%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants
  • Tejasvi DesaiResearcherExecutive Officer, DirectorLinked by 1 patent
  • Sarah LeeResearcherExecutive Officer, DirectorLinked by $1.8M in grants as PI
  • Anna BaileyExecutive Officer, DirectorNamed in SEC Form D filings

What it has protected

USPTO · 1 granted of 4
  • GrantedSystem And Method For Injection And Retraction Of FluidUSPTOUS 12,128,152
  • PendingSterilizable Peritoneal Dialysis Connection DeviceUSPTOApplication 17309273
  • PendingSystem And Method For Injection And Retraction Of FluidUSPTOApplication PCTUS2021065039
Show all 4 patent records
  • System And Method For Injection And Retraction Of FluidOct 29, 2024 · US 12,128,152Granted
  • Sterilizable Peritoneal Dialysis Connection DeviceJan 20, 2022 · Application 17309273Pending
  • System And Method For Injection And Retraction Of FluidApplication PCTUS2021065039Pending
  • System And Method For Injection And Retraction Of FluidApplication 63129675Pending
  • PIEZO THERAPEUTICS, INC.Similar federal contract value in Medtech · null in contracts
  • Neurodyne, Inc.Similar federal contract value in Medtech · null in contracts
  • PROMEDIX, INC.Similar federal contract value in Medtech · null in contracts
  • MAGSORBEO BIOMEDICAL CORPSimilar federal contract value in Medtech · null in contracts
  • REDUX HOLDINGS INCSimilar federal contract value in Medtech · null in contracts
  • Clarisond IncSimilar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .